Helai P. Mohammad

5.3k total citations · 1 hit paper
37 papers, 2.5k citations indexed

About

Helai P. Mohammad is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Helai P. Mohammad has authored 37 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Hematology. Recurrent topics in Helai P. Mohammad's work include Epigenetics and DNA Methylation (25 papers), Cancer-related gene regulation (16 papers) and Histone Deacetylase Inhibitors Research (11 papers). Helai P. Mohammad is often cited by papers focused on Epigenetics and DNA Methylation (25 papers), Cancer-related gene regulation (16 papers) and Histone Deacetylase Inhibitors Research (11 papers). Helai P. Mohammad collaborates with scholars based in United States, Belgium and Netherlands. Helai P. Mohammad's co-authors include Stephen B. Baylin, Heather M. O’Hagan, Olena Barbash, Caretha L. Creasy, James G. Herman, Joyce E. Ohm, Kelly M. McGarvey, Kornel E. Schuebel, Leslie Cope and D. Neil Watkins and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.

In The Last Decade

Helai P. Mohammad

36 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

2007 805 citations Joyce E. Ohm, Kelly M. McGarvey et al. Nature Genetics profile →

Peers

Countries citing papers authored by Helai P. Mohammad

Since Specialization

Citations

This map shows the geographic impact of Helai P. Mohammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helai P. Mohammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helai P. Mohammad more than expected).

Fields of papers citing papers by Helai P. Mohammad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helai P. Mohammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helai P. Mohammad. The network helps show where Helai P. Mohammad may publish in the future.

Co-authorship network of co-authors of Helai P. Mohammad

This figure shows the co-authorship network connecting the top 25 collaborators of Helai P. Mohammad. A scholar is included among the top collaborators of Helai P. Mohammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helai P. Mohammad. Helai P. Mohammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a Novel Series of iso-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders 2025 ·Journal of Medicinal Chemistry ·(unknown), Harshil Dhruv, Qiaolin Deng, Matthew Tudor, (unknown), Rakesh Nagilla, Larry J. Jolivette, Cory Rice, Peter P. Orth, Elham Behshad, Corey Strickland, Helai P. Mohammad, Longchuan Bai, Donna McEachern, Shaomeng Wang, Zhihua Sui, E. Scott Priestley	0
2	Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy 2025 ·Nature Communications ·Zhixiang Chen, Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern, Paul D. Kirchhoff, Rakesh Nagilla, Larry J. Jolivette, Cory Rice, Peter Orth, (unknown), E. Scott Priestley, Helai P. Mohammad, (unknown), Bo Wen, Duxin Sun, Zhihua Sui, Shaomeng Wang	6
3	Overcoming CK1α liability in the discovery of a series of isoIndolinone Glutarimides as selective IKZF2 molecular glue degraders 2025 ·Bioorganic & Medicinal Chemistry Letters ·Xuqing Zhang, Qiaolin Deng, Harshil Dhruv, Matthew Tudor, Rakesh Nagilla, Larry J. Jolivette, Cory Rice, Peter P. Orth, Elham Behshad, (unknown), Helai P. Mohammad, Zhihua Sui, E. Scott Priestley	1
4	Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer 2023 ·BMC Cancer ·Shane W. O’Brien, (unknown), Christine Thompson, Boris G. Wilson, Anastasia Wyce, Vivek Mahajan, Ryan G. Kruger, Helai P. Mohammad, (unknown)	16
5	Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell–Mediated Antitumor Immune Responses 2022 ·Cancer Immunology Research ·Andrew Fedoriw, Leilei Shi, Shane W. O’Brien, Kimberly N. Smitheman, Yunfei Wang, Jiakai Hou, Christian Sherk, Satyajit Rajapurkar, Jenny Laraio, Leila J. Williams, Chunyu Xu, Guangchun Han, Qin Feng, Mark T. Bedford, Linghua Wang, Olena Barbash, Ryan G. Kruger, Patrick Hwu, Helai P. Mohammad, Weiyi Peng	26
6	Lysine-Specific Demethylase 1 Mediates AKT Activity and Promotes Epithelial-to-Mesenchymal Transition in PIK3CA -Mutant Colorectal Cancer 2019 ·Molecular Cancer Research ·(unknown), Robert A. Policastro, (unknown), Shruthi Sriramkumar, Ning Ding, Xiaoyu Lu, Helai P. Mohammad, Sha Cao, Jay H. Kalin, Philip A. Cole, Gabriel E. Zentner, Heather M. O’Hagan	36
7	Phase I, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of GSK2879552 in Relapsed/Refractory SCLC 2019 ·Journal of Thoracic Oncology ·Todd M. Bauer, Benjamin Besse, Alex Martínez‐Martí, José Trigo, Víctor Moreno, Pilar Garrido, Geraldine Ferron‐Brady, Yuehui Wu, Jennifer Park, (unknown), Ryan G. Kruger, Helai P. Mohammad, Marc Ballas, Arindam Dhar, Ramaswamy Govindan	61
8	Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma 2019 ·Nature Communications ·Catherine Lee, Vasilisa A. Rudneva, Serap Erkek, Marc Zapatka, (unknown), Silvia K. Tacheva-Grigorova, Alexandra Garancher, Jessica M. Rusert, Ozlem Aksoy, (unknown), Helai P. Mohammad, Jianxun Wang, William A. Weiss, H. Leighton Grimes, Stefan M. Pfister, Paul A. Northcott, Robert J. Wechsler‐Reya	65
9	LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML 2018 ·Blood ·Monica Cusan, Sheng F. Cai, Helai P. Mohammad, Andrei V. Krivtsov, Alan Chramiec, Evangelia Loizou, Matthew D. Witkin, Kimberly N. Smitheman, Daniel G. Tenen, Min Ye, Britta Will, Ulrich Steidl, Ryan G. Kruger, Ross L. Levine, Hugh Young Rienhoff, Richard P. Koche, Scott A. Armstrong	81
10	Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis 2018 ·Nature Immunology ·Katerina Hatzi, Huimin Geng, Ashley S. Doane, Cem Meydan, (unknown), Mariano Cárdenas, Cihangir Duy, Hao Shen, María Nieves Calvo Vidal, Timour Baslan, Helai P. Mohammad, Ryan G. Kruger, Rita Shaknovich, Ann M. Haberman, Giorgio Inghirami, Scott W. Lowe, Ari Melnick	60
11	Structure-Based Design of a Novel SMYD3 Inhibitor that Bridges the SAM-and MEKK2-Binding Pockets 2016 ·Structure ·Glenn S. Van Aller, Alan P. Graves, P.A. Elkins, William G. Bonnette, Patrick McDevitt, Francesca Zappacosta, Roland S. Annan, (unknown), Dai‐Shi Su, Christopher L. Carpenter, Helai P. Mohammad, Ryan G. Kruger	42
12	The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes 2013 ·Oncogene ·Yi Cai, (unknown), Klaas de Lint, Paul Roepman, (unknown), Li‐Rong Yu, Wei Wang, Janneke van Blijswijk, Helai P. Mohammad, Iris de Rink, René Bernards, Stephen B. Baylin	99
13	DNMT1 modulates gene expression without its catalytic activity partially through its interactions with histone-modifying enzymes 2012 ·Nucleic Acids Research ·(unknown), Helai P. Mohammad, Benjamin R. Leadem, Hariharan Easwaran, Yi Cai, Leander Van Neste, Stephen B. Baylin	93
14	Loss of a single Hic1 allele accelerates polyp formation in ApcΔ716 mice 2011 ·Oncogene ·Helai P. Mohammad, (unknown), (unknown), Benjamin R. Leadem, (unknown), James G. Herman, Craig M. Hooker, D. Neil Watkins, Baktiar Karim, David L. Huso, S B Baylin	23
15	Aberrant Silencing of Cancer-Related Genes by CpG Hypermethylation Occurs Independently of Their Spatial Organization in the Nucleus 2010 ·Cancer Research ·Hariharan Easwaran, Leander Van Neste, Leslie Cope, Subhojit Sen, Helai P. Mohammad, (unknown), Jeanne B. Lawrence, James G. Herman, Kornel E. Schuebel, Stephen B. Baylin	23
16	Linking cell signaling and the epigenetic machinery 2010 ·Nature Biotechnology ·Helai P. Mohammad, Stephen B. Baylin	64
17	Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia 2010 ·Epigenetics ·Elizabeth A. Griffiths, Steven D. Gore, Craig M. Hooker, Helai P. Mohammad, Michael A. McDevitt, B. Douglas Smith, Judith E. Karp, James G. Herman, Hetty E. Carraway	41
18	Polycomb CBX7 Promotes Initiation of Heritable Repression of Genes Frequently Silenced with Cancer-Specific DNA Hypermethylation 2009 ·Cancer Research ·Helai P. Mohammad, Yi Cai, Kelly M. McGarvey, Hariharan Easwaran, Leander Van Neste, Joyce E. Ohm, Heather M. O’Hagan, Stephen B. Baylin	61
19	Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island 2008 ·PLoS Genetics ·Heather M. O’Hagan, Helai P. Mohammad, Stephen B. Baylin	305
20	A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing breakdown → 2007 ·Nature Genetics ·Joyce E. Ohm, Kelly M. McGarvey, Xiaobing Yu, Linzhao Cheng, Kornel E. Schuebel, Leslie Cope, Helai P. Mohammad, Wei Chen, Vincent C. Daniel, Wayne Yu, David M. Berman, Thomas Jenuwein, Kevin Pruitt, Saul J. Sharkis, D. Neil Watkins, James G. Herman, Stephen B. Baylin	805

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact